Intrepid Managed Discovery, Inc. (Intrepid) simplifies management of the Litigation Life Cycle by providing digital forensic, data processing, hosting, and managed document review services to AM LAW 500 and Fortune 500 companies as a managed services partner. Intrepid’s process and technology portfolio leverages Agile Methodology principals and consists of services and resources that are highly scalable on demand.

In the context of an increasingly commoditized eDiscovery landscape, the prevailing narrative often centers around promoting technological advancements and the latest trends, inadvertently leading to a state of bewilderment among end users. At Intrepid, we hold a divergent viewpoint, positing that technology represents only a segment of the comprehensive equation.

Our foremost objective is to engineer a tailored and impeccably timed process, one that zeroes in on distinct industries, enhances the client journey, and adheres to their legal budgetary considerations. In effect, this approach relegates the responsibility of overseeing the foundational process and pertinent technological recommendations – best aligned with the requisites of each case and investigation – to our adept professionals.

In doing so, our clients are empowered to harness avant-garde solutions and a cadre of specialists, all without the incessant need to acquaint themselves with novel software iterations. This strategic orientation liberates them to concentrate their energies on furnishing superlative legal counsel to their own clientele.


From collection to courtroom, Intrepid provides a full range of eDiscovery and litigation support services to help clients optimize their matters on time and within budget.

  • Forensic Investigations
  • Processing and Hosting
  • Managed Document Review
  • Court Reporting / Trial Tech Support

Managed Document Review - Pharmaceutical Industry Expertise

Intrepid's Managed Review service places a distinct emphasis on serving the Pharmaceutical Industry, particularly in the context of litigation arising from the Drug Price Competition and Patent Term Restoration Act, commonly referred to as the Hatch-Waxman Act. Our proficiency in this arena is underscored by our comprehensive experience and adeptness in navigating the intricate landscape of the pharmaceutical sector, including its specialized terminology. This obviates the need for us to elucidate fundamental concepts like Paragraph III, IV, FTF, FTM, NDA, ANDA, and API to our review team.

Our practice is dedicated to providing legal representation to both generic and brand pharmaceutical enterprises. The core of our Pharmaceutical Review division is comprised of seasoned professionals with extensive Hatch-Waxman experience, bolstered by a team of attorneys well-versed in scientific and chemical disciplines. Our reviewers boast a track record of having successfully undertaken anywhere from 40 to over 100 Hatch-Waxman reviews. Acknowledging the potential international scope of these cases, we are also equipped to furnish our clients with multi-lingual review capabilities.

Engage With Intrepid

To learn more about our services, approach and team, please visit us at

Data Centers

RelativityOne - US

Parkash Khatri
Founder & CEO

Product Offerings:

  • RelativityOne

Partner Type

RelativityOne Certified Partner

Partner Since 2021

Relativity Certifications

Relativity Experts (1)
Relativity Certified Administrator (1)
Relativity Data Management Specialist (1)
Relativity Processing Specialist (3)
Relativity Review Management Specialist (4)
RelativityOne Certified Pro (3)